Stay updated on Zephyrus I Clinical Trial
Sign up to get notified when there's something new on the Zephyrus I Clinical Trial page.

Latest updates to the Zephyrus I Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedCore content updated with government funding status and operating guidance plus a new software version (v3.2.0) replacing the old v3.0.2.SummaryDifference2%

- Check29 days agoChange DetectedRemoved major drug-safety and quality topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs), significantly reducing core content about drug quality and safety.SummaryDifference0.2%

- Check37 days agoChange Detected- The page now shows a new revision label: v3.0.2, replacing v3.0.1. - A stray “Back to Top” item was removed. Overall, this is a minor update focused on versioning and a small UI change, with no impact on core content, pricing, or availability.SummaryDifference0.1%

- Check44 days agoChange DetectedVersion updated from v3.0.0 to v3.0.1, and a 'Back to Top' link has been added. Core content, pricing, stock, and time-slot data remain unchanged.SummaryDifference0.1%

- Check58 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new facility names and locations across various countries, as well as the inclusion of new medical resources related to interstitial lung disease and drug safety. Notably, previous entries for certain locations and resources have been removed.SummaryDifference14%

- Check73 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.SummaryDifference0.0%

Stay in the know with updates to Zephyrus I Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zephyrus I Clinical Trial page.